MicroRNAs of Epstein-Barr virus control innate and adaptive anti-viral immunity.
J. Virol. 91:e01667-16 (2017)
More than 90% of humanity is infected with Epstein-Barr virus (EBV) lifelong. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known that act as immunoevasins preventing or reducing recognition of EBV-infected cells. Only recently, microRNAs of EBV were identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory miRNAs of herpesviruses.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cancer ; Human Herpesviruses ; Immune Evasion ; Immune Surveillance ; Microrna; T-cell Responses; Noncoding Rnas; Nasopharyngeal Carcinoma; Encoded Micrornas; Viral Mirnas; Ebv; Expression; Infection; Target; Modulation
Keywords plus
Language
english
Publication Year
2017
Prepublished in Year
HGF-reported in Year
2017
ISSN (print) / ISBN
0022-538X
e-ISSN
1098-5514
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 91,
Issue: 16,
Pages: ,
Article Number: e01667-16
Supplement: ,
Series
Publisher
American Society for Microbiology (ASM)
Publishing Place
Washington
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501500-001
Grants
Copyright
Erfassungsdatum
2017-07-17